Advertisement

Prolactin (PRL) in Adipose Tissue: Regulation and Functions

  • Nira Ben-JonathanEmail author
  • Eric Hugo
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 846)

Abstract

New information concerning the effects of prolactin (PRL) on metabolic processes warrants reevaluation of its overall metabolic actions. PRL affects metabolic homeostasis by regulating key enzymes and transporters associated with glucose and lipid metabolism in several target organs. In the lactating mammary gland, PRL increases the production of milk proteins, lactose, and lipids. In adipose tissue, PRL generally suppresses lipid storage and adipokine release and affect adipogenesis. A specific case is made for PRL in the human breast and adipose tissues, where it acts as a circulating hormone and an autocrine/paracrine factor. Although its overall effects on body composition are both modest and species-specific, PRL may be involved in the manifestation of insulin resistance.

Keywords

Brown Adipocyte Hormone Sensitive Lipase LS14 Cell Lactate Mammary Gland Adipose Tissue Explants 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by NIH grants ES02909 and CA096613, DOD grants BC05725 and AR110050, CCTST, and Ride Cincinnati Pilot Grants

References

  1. 1.
    Trott JF, Vonderhaar BK, Hovey RC (2008) Historical perspectives of prolactin and growth hormone as mammogens, lactogens and galactagogues for the future! J Mammary Gland Biol Neoplasia 13:3–11Google Scholar
  2. 2.
    Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639–669PubMedGoogle Scholar
  3. 3.
    Khurana S, Kuns R, Ben-Jonathan N (1999) Heparin-binding property of human prolactin: a novel aspect of prolactin biology. Endocrinology 140:1026–1029PubMedGoogle Scholar
  4. 4.
    Prigent-Tessier A, Tessier C, Hirosawa-Takamori M, Boyer C, Ferguson-Gottschall S, Gibori G (1999) Rat decidual prolactin. Identification, molecular cloning, and characterization. J Biol Chem 274:37982–37989PubMedGoogle Scholar
  5. 5.
    Steinmetz RW, Grant AL, Malven PV (1993) Transcription of prolactin gene in milk secretory cells of the rat mammary gland. J Endocrinol 136:271–276PubMedGoogle Scholar
  6. 6.
    Chen CC, Stairs DB, Boxer RB, Belka GK, Horseman ND, Alvarez JV et al (2012) Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev 26:2154–2168PubMedCentralPubMedGoogle Scholar
  7. 7.
    Alam SM, Konno T, Dai G, Lu L, Wang D, Dunmore JH et al (2007) A uterine decidual cell cytokine ensures pregnancy-dependent adaptations to a physiological stressor. Development 134:407–415PubMedGoogle Scholar
  8. 8.
    Forsyth IA, Wallis M (2002) Growth hormone and prolactin–molecular and functional evolution. J Mammary Gland Biol Neoplasia 7:291–312PubMedGoogle Scholar
  9. 9.
    Newbern D, Freemark M (2011) Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 18:409–416PubMedGoogle Scholar
  10. 10.
    Ben-Jonathan N, LaPensee CR, LaPensee EW (2008) What can we learn from rodents about prolactin in humans? Endocr Rev 29:1–41PubMedCentralPubMedGoogle Scholar
  11. 11.
    Sinha YN (1995) Structural variants of prolactin: occurrence and physiological significance. Endocr Rev 16:354–369PubMedGoogle Scholar
  12. 12.
    Fahie-Wilson MN, John R, Ellis AR (2005) Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 42:175–192PubMedGoogle Scholar
  13. 13.
    Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292–1299PubMedGoogle Scholar
  14. 14.
    Clapp C, Gonzalez C, Macotela Y, Aranda J, Rivera JC, Garcia C et al (2006) Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Front Horm Res 35:64–73PubMedGoogle Scholar
  15. 15.
    Pellegrini I, Gunz G, Grisoli F, Jaquet P (1990) Different pathways of secretion for glycosylated and nonglycosylated human prolactin. Endocrinology 126:1087–1095PubMedGoogle Scholar
  16. 16.
    Bollengier F, Mahler A, Braet C, Claeyssens M, Vanhaelst L (2001) Glycosylated rat prolactin: isolation and structural characterization. Arch Physiol Biochem 109:180–190PubMedGoogle Scholar
  17. 17.
    Walker AM (2007) S179D prolactin: antagonistic agony! Mol Cell Endocrinol 276:1–9PubMedCentralPubMedGoogle Scholar
  18. 18.
    Ueda E, Ozerdem U, Chen YH, Yao M, Huang KT, Sun H et al (2006) A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocr Relat Cancer 13:95–111PubMedGoogle Scholar
  19. 19.
    Kossiakoff AA (2004) The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors. Adv Protein Chem 68:147–169PubMedGoogle Scholar
  20. 20.
    Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH, Dufau ML (2002) Complex 5′ genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization. Endocrinology 143:2139–2142PubMedGoogle Scholar
  21. 21.
    Bernichtein S, Touraine P, Goffin V (2010) New concepts in prolactin biology. J Endocrinol 206:1–11PubMedGoogle Scholar
  22. 22.
    Plotnikov A, Varghese B, Tran TH, Liu C, Rui H, Fuchs SY (2009) Impaired turnover of prolactin receptor contributes to transformation of human breast cells. Cancer Res 69:3165–3172PubMedCentralPubMedGoogle Scholar
  23. 23.
    Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1–27PubMedCentralPubMedGoogle Scholar
  24. 24.
    Swaminathan G, Varghese B, Fuchs SY (2008) Regulation of prolactin receptor levels and activity in breast cancer. J Mammary Gland Biol Neoplasia 13:81–91PubMedCentralPubMedGoogle Scholar
  25. 25.
    Brooks CL (2012) Molecular mechanisms of prolactin and its receptor. Endocr Rev 33:504–525PubMedCentralPubMedGoogle Scholar
  26. 26.
    Meng J, Tsai-Morris CH, Dufau ML (2004) Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma. Cancer Res 64:5677–5682PubMedGoogle Scholar
  27. 27.
    Binart N, Bachelot A, Bouilly J (2010) Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab 21:362–368PubMedGoogle Scholar
  28. 28.
    Qazi AM, Tsai-Morris CH, Dufau ML (2006) Ligand-independent homo- and hetero-dimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol 20:1912–1923PubMedGoogle Scholar
  29. 29.
    Ali S, Pellegrini I, Kelly PA (1991) A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J Biol Chem 266:20110–20117PubMedGoogle Scholar
  30. 30.
    Utama FE, LeBaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU et al (2006) Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. J Endocrinol 188:589–601PubMedGoogle Scholar
  31. 31.
    Semprini S, McNamara AV, Awais R, Featherstone K, Harper CV, McNeilly JR et al (2012) Peritonitis activates transcription of the human prolactin locus in myeloid cells in a humanized transgenic rat model. Endocrinology 153:2724–2734PubMedGoogle Scholar
  32. 32.
    Christensen HR, Murawsky MK, Horseman ND, Willson TA, Gregerson KA (2013) Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues. Endocrinology 154:4777–4789PubMedCentralPubMedGoogle Scholar
  33. 33.
    Frank SJ (2002) Receptor dimerization in GH and erythropoietin action–it takes two to tango, but how? Endocrinology 143:2–10PubMedGoogle Scholar
  34. 34.
    Gadd SL, Clevenger CV (2006) Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol 20:2734–2746PubMedGoogle Scholar
  35. 35.
    Goffin V, Bernichtein S, Touraine P, Kelly PA (2005) Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 26:400–422PubMedGoogle Scholar
  36. 36.
    Gutzman JH, Rugowski DE, Schroeder MD, Watters JJ, Schuler LA (2004) Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells. Mol Endocrinol 18:3064–3075PubMedCentralPubMedGoogle Scholar
  37. 37.
    Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Gonzalez L, Porque PG, Leon J et al (2004) Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Oncogene 23:7378–7390PubMedGoogle Scholar
  38. 38.
    Hennighausen L, Robinson GW (2008) Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev 22:711–721PubMedCentralPubMedGoogle Scholar
  39. 39.
    Ahima RS (2006) Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(Suppl 5):242S–249SGoogle Scholar
  40. 40.
    Ailhaud G (2006) Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol 329:570–577PubMedGoogle Scholar
  41. 41.
    Tang QQ, Lane MD (2012) Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 81:715–736PubMedGoogle Scholar
  42. 42.
    Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM (2000) Transcriptional regulation of adipogenesis. Genes Dev 14:1293–1307PubMedGoogle Scholar
  43. 43.
    Herold C, Rennekampff HO, Engeli S (2013) Apoptotic pathways in adipose tissue. Apoptosis 18:911–916PubMedGoogle Scholar
  44. 44.
    Arner P, Spalding KL (2010) Fat cell turnover in humans. Biochem Biophys Res Commun 396:101–104PubMedGoogle Scholar
  45. 45.
    Ortega FJ, Fernandez-Real JM (2013) Inflammation in adipose tissue and fatty acid anabolism: when enough is enough! Horm Metab Res 45:1009–1019PubMedGoogle Scholar
  46. 46.
    Harwood HJ Jr (2012) The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 63:57–75PubMedGoogle Scholar
  47. 47.
    Poulos SP, Hausman DB, Hausman GJ (2010) The development and endocrine functions of adipose tissue. Mol Cell Endocrinol 323:20–34PubMedGoogle Scholar
  48. 48.
    Ben-Jonathan N, Hugo ER, Brandebourg TD (2006) LaPensee CR. Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 17:110–116PubMedGoogle Scholar
  49. 49.
    Trayhurn P, Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329–339PubMedGoogle Scholar
  50. 50.
    Zafrir B (2013) Brown adipose tissue: research milestones of a potential player in human energy balance and obesity. Horm Metab Res 45:774–785PubMedGoogle Scholar
  51. 51.
    Peschechera A, Eckel J (2013) “Browning” of adipose tissue–regulation and therapeutic perspectives. Arch Physiol Biochem 119:151–160PubMedGoogle Scholar
  52. 52.
    Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF (2002) Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 34:616–621PubMedGoogle Scholar
  53. 53.
    Lafontan M (2012) Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol 302:C327–C359PubMedGoogle Scholar
  54. 54.
    Bloor ID, Symonds ME (2014) Sexual dimorphism in white and brown adipose tissue with obesity and inflammation. Horm Behav Google Scholar
  55. 55.
    Arner P (2001) Regional differences in protein production by human adipose tissue. Biochem Soc Trans 29:72–75PubMedGoogle Scholar
  56. 56.
    Potenza MV, Mechanick JI (2009) The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 24:560–577PubMedGoogle Scholar
  57. 57.
    Cinti S (2005) The adipose organ. Prostaglandins Leukot Essent Fatty Acids 73:9–15PubMedGoogle Scholar
  58. 58.
    Hovey RC, Aimo L (2010) Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia 15:279–290PubMedCentralPubMedGoogle Scholar
  59. 59.
    Su Y, Shankar K, Rahal O, Simmen RC (2011) Bidirectional signaling of mammary epithelium and stroma: implications for breast cancer–preventive actions of dietary factors. J Nutr Biochem 22:605–611PubMedGoogle Scholar
  60. 60.
    Carre N, Binart N (2014) Prolactin and adipose tissue. Biochimie 97:16–21PubMedGoogle Scholar
  61. 61.
    Gregoire FM (2001) Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) 226:997–1002Google Scholar
  62. 62.
    MacDougald OA, Mandrup S (2002) Adipogenesis: forces that tip the scales. Trends Endocrinol Metab 13:5–11PubMedGoogle Scholar
  63. 63.
    Letexier D, Pinteur C, Large V, Frering V, Beylot M (2003) Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res 44:2127–2134PubMedGoogle Scholar
  64. 64.
    Jeffcoat R (2007) Obesity—a perspective based on the biochemical interrelationship of lipids and carbohydrates. Med Hypotheses 68:1159–1171PubMedGoogle Scholar
  65. 65.
    Large V, Peroni O, Letexier D, Ray H, Beylot M (2004) Metabolism of lipids in human white adipocyte. Diabetes Metab 30:294–309PubMedGoogle Scholar
  66. 66.
    Proenca AR, Sertie RA, Oliveira AC, Campaaa AB, Caminhotto RO, Chimin P et al (2014) New concepts in white adipose tissue physiology. Braz J Med Biol Res 47:192–205PubMedCentralPubMedGoogle Scholar
  67. 67.
    Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A (2009) Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 50:3–21PubMedGoogle Scholar
  68. 68.
    Ahmadian M, Wang Y, Sul HS (2010) Lipolysis in adipocytes. Int J Biochem Cell Biol 42:555–559PubMedCentralPubMedGoogle Scholar
  69. 69.
    Wang S, Soni KG, Semache M, Casavant S, Fortier M, Pan L et al (2008) Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab 95:117–126PubMedGoogle Scholar
  70. 70.
    Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J (2008) Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19:130–137PubMedGoogle Scholar
  71. 71.
    Trujillo ME, Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27:762–778PubMedGoogle Scholar
  72. 72.
    Wauman J, Tavernier J (2011) Leptin receptor signaling: pathways to leptin resistance. Front Biosci (Landmark Ed) 16:2771–2793Google Scholar
  73. 73.
    Munzberg H, Bjornholm M, Bates SH, Myers MG Jr (2005) Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62:642–652PubMedGoogle Scholar
  74. 74.
    Perry B, Wang Y (2012) Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes 2:e26PubMedCentralPubMedGoogle Scholar
  75. 75.
    Li FY, Lam KS, Xu A (2012) Therapeutic perspectives for adiponectin: an update. Curr Med Chem 19:5513–5523PubMedGoogle Scholar
  76. 76.
    Turer AT, Scherer PE (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55:2319–2326PubMedGoogle Scholar
  77. 77.
    Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556PubMedGoogle Scholar
  78. 78.
    Zinger M, McFarland M, Ben-Jonathan N (2003) Prolactin expression and secretion by human breast glandular and adipose tissue. J Clin Endocrinol Metab 88:689–696PubMedGoogle Scholar
  79. 79.
    Hugo ER, Borcherding DC, Gersin KS, Loftus J, Ben-Jonathan N (2008) Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes. J Clin Endocrinol Metab 93:4006–4012PubMedCentralPubMedGoogle Scholar
  80. 80.
    Bouckenooghe T, Sisino G, Aurientis S, Chinetti-Gbaguidi G, Kerr-Conte J, Staels B et al (2014) Adipose tissue macrophages (ATM) of obese patients are releasing increased levels of prolactin during an inflammatory challenge: a role for prolactin in diabesity? Biochim Biophys Acta 1842:584–593PubMedGoogle Scholar
  81. 81.
    Ernst B, Thurnheer M, Schultes B (2009) Basal serum prolactin levels in obesity–unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss. Obes Surg 19:1159–1162PubMedGoogle Scholar
  82. 82.
    Chirico V, Cannavo S, Lacquaniti A, Salpietro V, Mandolfino M, Romeo PD et al (2013) Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction. Clin Endocrinol (Oxf) 79:537–544Google Scholar
  83. 83.
    Featherstone K, White MR, Davis JR (2012) The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics. J Neuroendocrinol 24:977–990PubMedCentralPubMedGoogle Scholar
  84. 84.
    Pohnke Y, Kempf R, Gellersen B (1999) CCAAT/enhancer-binding proteins are mediators in the protein kinase A- dependent activation of the decidual prolactin promoter. J Biol Chem 274:24808–24818PubMedGoogle Scholar
  85. 85.
    Watanabe K, Kessler CA, Bachurski CJ, Kanda Y, Richardson BD, Stanek J et al (2001) Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Mol Endocrinol 15:638–653PubMedGoogle Scholar
  86. 86.
    McFarland-Mancini M, Hugo E, Loftus J, Ben-Jonathan N (2006) Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem Biophys Res Commun 344:9–16PubMedGoogle Scholar
  87. 87.
    Brar AK, Kessler CA, Handwerger S (2002) An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression. J Mol Endocrinol 29:99–112PubMedGoogle Scholar
  88. 88.
    Borcherding DC, Hugo ER, Idelman G, De SA, Richtand NW, Loftus J et al (2011) Dopamine receptors in human adipocytes: expression and functions. PLoS ONE 6:e25537PubMedCentralPubMedGoogle Scholar
  89. 89.
    Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N (2006) LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 147:306–313PubMedGoogle Scholar
  90. 90.
    Ben-Jonathan N (1985) Dopamine: a prolactin-inhibiting hormone. Endocr Rev 6:564–589PubMedGoogle Scholar
  91. 91.
    Golander A, Barrett J, Hurley T, Barry S, Handwerger S (1979) Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro. J Clin Endocrinol Metab 49:787–789PubMedGoogle Scholar
  92. 92.
    Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C et al (1999) Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab 84:2523–2531PubMedGoogle Scholar
  93. 93.
    Ghosh D (2007) Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 64:2013–2022PubMedGoogle Scholar
  94. 94.
    Eldrup E (2004) Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid. Dan Med Bull 51:34–62PubMedGoogle Scholar
  95. 95.
    Strobel G, Werle E, Weicker H (1990) Isomer specific kinetics of dopamine beta-hydroxylase and arylsulfatase towards catecholamine sulfates. Biochem Int 20:343–351PubMedGoogle Scholar
  96. 96.
    Marano RJ, Ben-Jonathan N (2014) Minireview: extrapituitary prolactin: an update on the distribution, regulation, and functions. Mol Endocrinol 28:622–633PubMedGoogle Scholar
  97. 97.
    Naef L, Woodside B (2007) Prolactin/leptin interactions in the control of food intake in rats. Endocrinology 148:5977–5983PubMedGoogle Scholar
  98. 98.
    Lisboa PC, Passos MC, Dutra SC, Bonomo IT, Denolato AT, Reis AM et al (2006) Leptin and prolactin, but not corticosterone, modulate body weight and thyroid function in protein-malnourished lactating rats. Horm Metab Res 38:295–299PubMedGoogle Scholar
  99. 99.
    Augustine RA, Grattan DR (2008) Induction of central leptin resistance in hyperphagic pseudopregnant rats by chronic prolactin infusion. Endocrinology 149:1049–1055PubMedGoogle Scholar
  100. 100.
    LaPensee CR, Horseman ND, Tso P, Brandebourg TD, Hugo ER, Ben-Jonathan N (2006) The prolactin-deficient mouse has an unaltered metabolic phenotype. Endocrinology 147:4638–4645PubMedGoogle Scholar
  101. 101.
    Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P (2001) Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142:532–537PubMedGoogle Scholar
  102. 102.
    Auffret J, Viengchareun S, Carre N, Denis RG, Magnan C, Marie PY et al (2012) Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-diet-induced obesity. FASEB J 26:3728–3737PubMedGoogle Scholar
  103. 103.
    Le JA, Wilson HM, Shehu A, Devi YS, Aguilar T, Gibori G (2011) Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype. Horm Metab Res 43:931–937PubMedCentralPubMedGoogle Scholar
  104. 104.
    Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejias MA et al (2001) Antipsychotic drugs and obesity: is prolactin involved? Can J Psychiatry 46:829–834PubMedGoogle Scholar
  105. 105.
    Greenman Y, Tordjman K, Stern N (1998) Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 48:547–553Google Scholar
  106. 106.
    Berinder K, Nystrom T, Hoybye C, Hall K, Hulting AL (2011) Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 14:199–207PubMedGoogle Scholar
  107. 107.
    Nilsson L, Olsson AH, Isomaa B, Groop L, Billig H, Ling C (2011) A common variant near the PRL gene is associated with increased adiposity in males. Mol Genet Metab 102:78–81PubMedGoogle Scholar
  108. 108.
    Oliver CH, Watson CJ (2013) Making milk: a new link between STAT5 and Akt1. JAKSTAT 2:e23228PubMedCentralPubMedGoogle Scholar
  109. 109.
    Iwasaka T, Umemura S, Kakimoto K, Koizumi H, Osamura YR (2000) Expression of prolactin mRNA in rat mammary gland during pregnancy and lactation. J Histochem Cytochem 48:389–396PubMedGoogle Scholar
  110. 110.
    Jahn GA, Edery M, Belair L, Kelly PA, Djiane J (1991) Prolactin receptor gene expression in rat mammary gland and liver during pregnancy and lactation. Endocrinology 128:2976–2984PubMedGoogle Scholar
  111. 111.
    Ueda EK, Huang K, Nguyen V, Ferreira M, Andre S, Walker AM (2011) Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. Cell Tissue Res 346:175–189PubMedGoogle Scholar
  112. 112.
    Flint DJ, Binart N, Kopchick J, Kelly P (2003) Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary 6:97–102PubMedGoogle Scholar
  113. 113.
    Ellis LA, Picciano MF (1995) Bioactive and immunoreactive prolactin variants in human milk. Endocrinology 136:2711–2720PubMedGoogle Scholar
  114. 114.
    Ben-Jonathan N, Munsick RA (1980) Dopamine and prolactin in human pregnancy. J Clin Endocrinol Metab 51:1019–1025PubMedGoogle Scholar
  115. 115.
    Grosvenor CE, Picciano MF, Baumrucker CR (1993) Hormones and growth factors in milk. Endocr Rev 14:710–728PubMedGoogle Scholar
  116. 116.
    Brandebourg TD, Bown JL, Ben-Jonathan N (2007) Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. Biochem Biophys Res Commun 357:408–413PubMedCentralPubMedGoogle Scholar
  117. 117.
    Fleenor D, Arumugam R, Freemark M (2006) Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 66:101–110PubMedGoogle Scholar
  118. 118.
    Stephens JM, Morrison RF, Pilch PF (1996) The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 271:10441–10444PubMedGoogle Scholar
  119. 119.
    Stewart WC, Baugh JE Jr, Floyd ZE, Stephens JM (2004) STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem Biophys Res Commun 324:355–359PubMedGoogle Scholar
  120. 120.
    Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H (2000) Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 14:307–316PubMedGoogle Scholar
  121. 121.
    Flint DJ, Binart N, Boumard S, Kopchick JJ, Kelly P (2006) Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J Endocrinol 191:101–111PubMedGoogle Scholar
  122. 122.
    Carre N, Solomon G, Gertler A, Binart N (2014) Effects of high affinity leptin antagonist on prolactin receptor deficient male mouse. PLoS ONE 9:e91422PubMedCentralPubMedGoogle Scholar
  123. 123.
    Zhao P, Stephens JM (2013) Identification of STAT target genes in adipocytes. JAKSTAT 2:e23092PubMedCentralPubMedGoogle Scholar
  124. 124.
    Ling C, Svensson L, Oden B, Weijdegard B, Eden B, Eden S et al (2003) Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J Clin Endocrinol Metab 88:1804–1808PubMedGoogle Scholar
  125. 125.
    Nilsson LA, Roepstorff C, Kiens B, Billig H, Ling C (2009) Prolactin suppresses malonyl-CoA concentration in human adipose tissue. Horm Metab Res 41:747–751PubMedGoogle Scholar
  126. 126.
    Hogan JC, Stephens JM (2005) The regulation of fatty acid synthase by STAT5A. Diabetes 54:1968–1975PubMedGoogle Scholar
  127. 127.
    Ling C, Billig H (2001) PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. Endocrinology 142:4880–4890PubMedGoogle Scholar
  128. 128.
    Gualillo O, Lago F, Garcia M, Menendez C, Senaris R, Casanueva FF et al (1999) Prolactin stimulates leptin secretion by rat white adipose tissue. Endocrinology 140:5149–5153PubMedGoogle Scholar
  129. 129.
    Balci H, Akgun-Dar K, Gazioglu N, Kapucu A, Bolayirli M, Oz B (2009) The relationship between prolactin (PRL), leptin, nitric oxide (NO), and cytokines in patients with hyperprolactinemia. Pituitary 12:170–176PubMedGoogle Scholar
  130. 130.
    Atmaca A, Bilgici B, Ecemis GC, Tuncel OK (2013) Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia. Endocr 44:756–761Google Scholar
  131. 131.
    Viengchareun S, Bouzinba-Segard H, Laigneau JP, Zennaro MC, Kelly PA, Bado A et al (2004) Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes. J Mol Endocrinol 33:679–691PubMedGoogle Scholar
  132. 132.
    Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC et al (2003) Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52:268–276PubMedGoogle Scholar
  133. 133.
    Nilsson L, Binart N, Bohlooly Y, Bramnert M, Egecioglu E, Kindblom J et al (2005) Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 331:1120–1126PubMedGoogle Scholar
  134. 134.
    Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M et al (2006) Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes. Endocr J 53:555–562PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Cancer BiologyUniversity of CincinnatiCincinnatiUSA

Personalised recommendations